Cited by 37Bone health and osteoporosis researchHormonal and reproductive studiesEstrogen and related hormone effects

Effect of testosterone, raloxifene and estrogen replacement on the microstructure and biomechanics of metaphyseal osteoporotic bones in orchiectomized male rats

Open access
Stuermer, E. K., Sehmisch, S., Tezval, M., Tezval, H., Rack, T., Boekhoff, J., Wuttke, W., Herrmann, T. R. W. +2 more·2009·World Journal of Urology

Abstract

INTRODUCTION: Currently, osteoporosis research is rarely undertaken in males but an increase in male life expectancy in the company of hypogonadism suggests the necessity for potential therapeutic options. MATERIALS AND METHODS: In this study, the changes in bone structure under standardized testosterone- (T), raloxifene- (R) and estrogen (E)-supplemented diets were analyzed in osteoporotic castrated male rats. RESULTS: Unexpected biomechanical results could be only explained by the histomorphometry, but not by BMD measurements obtained from the qCT. All tested substances showed a significant improvement in the trabecular network (trabecular bone area for C: 2.55 mm(2), T: 4.25 mm(2), R: 4.22 mm(2) and E: 4.28 mm(2)), and suggests that the bone structure was preserved. For the metaphyseal cortical bone, a significant loss was detected in T (CBP: 18.7%) compared to R (CBP: 30.0%), E (CBP: 26.8%) and even to the osteoporotic control (CBP: 28.6%). This explains the observed early mechanical final failure after T supplementation. However, due to the preserved trabecular bone in T, the occurrence of the first microfractures (yL: 49 +/- 21.4 N) was significantly later than in the osteoporotic control (yL: 39.5 +/- 15.5 N). Raloxifene performed well in hindering the bone loss associated with osteoporosis. However, its effect (yL: 83.3 +/- 16.5 N) did not approach the protective effect of E (yL: 99.2 +/- 21.1 N). CONCLUSION: Testosterone only preserved the deterioration of the trabecular bone but not of the cortical bone. Raloxifene prevented the bone loss associated with osteoporosis at all bony structures. This effect did not approach the protective effect of estrogen on trabecular bone, but it is more suitable for male individuals because it has no feminizing effects on the subject.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00345-009-0373-5

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Testosterone has a direct effect on bone through the androgen receptors present in osteoblasts that enhance bone proliferation, or it has an indirect effect through the aromatization changes to estrogen.

    “testosterone has a direct effect on bone through the androgen receptors present in osteoblasts that enhance bone proliferation [46–50], or it has an indirect effect through the aromatization changes to estrogen [51].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stuermer, E. K., Sehmisch, S., Tezval, M., Tezval, H., Rack, T., Boekhoff, J., Wuttke, W., Herrmann, T. R. W., Seidlova-Wuttke, D., & Stuermer, K. M.
Affiliations
  • University of Göttingen (DE)
  • Medizinische Hochschule Hannover (DE)
Corresponding author
Stuermer, E. K.
Venue
World Journal of Urology
Published
2009-02-17
Volume
27
Issue
4
Pages
547-555
ISSN
  • 0724-4983 (ISSN-L)
  • 1433-8726
OpenAlex
W2004100464
Cited by
37
References
26
Citations by year
2026: 1 · 2025: 1 · 2023: 3 · 2022: 4 · 2021: 3 · 2020: 4 · 2019: 1 · 2018: 4 · 2015: 1 · 2014: 1 · 2013: 1 · 2012: 4
FWCI
4.20
Type
journal article
Language
en
Open access
Locations
  • World Journal of Urology (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
  • GRO (submittedVersion, cc-by)
Topics
  • Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Estrogen and related hormone effects
Keywords
male osteoporosis, testosterone, raloxifene, estrogen replacement therapy, orchiectomy, hypogonadism, trabecular bone, cortical bone, bone microarchitecture, bone biomechanics, bone loss, histomorphometry, bone mineral density
MeSH terms
Administration, Oral, Animals, Biomechanical Phenomena, Bone and Bones, Bone Resorption, Disease Models, Animal, Estrogens, Male, Orchiectomy, Osteoporosis, Testosterone, Bone Density, Rats, Sprague-Dawley, Hormone Replacement Therapy, Raloxifene Hydrochloride, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review